Ownership and insider activity for Quantum BioPharma Ltd. (QNTM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.
Price
| Price | $3.65 |
| Market Cap | $23M |
| Exchange | NASDAQ |
| Country | CA |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7137 | $3.8M | $15.5M | $6.0M | $17.5M | $35.3M | $17.0M | $2.8M | $6.0M | $1.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $158036 | $23188 | $756100 | $1.2M | $4.3M |
| Receivables | 0 | $234201 | $979547 | $1.6M | $161342 | $500964 | $374377 | $7.4M | $3.8M | $230632 |
| Inventory | 0 | 0 | 0 | $709373 | 0 | 0 | 0 | 0 | $117242 | $52038 |
| Total Current Assets | $7137 | $4.3M | $16.6M | $8.6M | $26.9M | $45.9M | $17.9M | $11.1M | $12.1M | $6.5M |
| Property, Plant & Equipment | 0 | $6.6M | $8.9M | $9.0M | 0 | $168307 | $260925 | $120421 | $130382 | $169040 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | $16.8M | $13.4M | $16.2M | $12.0M | $5.4M | $4.9M | $4.5M |
| Total Assets | $7137 | $10.9M | $38.7M | $43.2M | $42.0M | $63.0M | $38.4M | $17.5M | $17.1M | $11.1M |
| Accounts Payable | $28309 | $1.0M | $1.3M | $3.4M | $2.1M | $3.0M | $2.8M | $3.2M | $3.3M | 0 |
| Short-term Debt | 0 | 0 | 0 | $1.4M | $384647 | $300549 | $300549 | $300549 | $771142 | $1.9M |
| Total Current Liabilities | $61434 | $1.0M | $1.3M | $6.8M | $5.6M | $8.7M | $7.8M | $4.6M | $6.7M | $6.0M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $61434 | $1.0M | $1.3M | $6.9M | $5.7M | $8.8M | $7.9M | $4.6M | $6.7M | $6.0M |
| Retained Earnings | -$1.3M | -$3.3M | -$19.5M | -$59.1M | -$90.9M | -$126.2M | -$144.2M | -$157.9M | -$172.1M | -$197.9M |
| Total Equity | -$54297 | $9.9M | $37.5M | $36.3M | $36.3M | $54.1M | $30.5M | $13.2M | $11.5M | $6.9M |
| Total Debt | 0 | 0 | 0 | $1.6M | $510609 | $555905 | $516423 | $339199 | $824922 | $1.9M |
| Net Debt | -$7137 | -$3.8M | -$15.5M | -$4.4M | -$17.0M | -$34.9M | -$16.5M | -$3.2M | -$6.4M | -$4.3M |
| Working Capital | -$54297 | $3.3M | $15.3M | $1.7M | $21.3M | $37.2M | $10.0M | $6.5M | $5.4M | $419295 |
Financial Health
| Piotroski F-Score | 1 |
| Altman Z-Score | -26.98 |
Related companies: ANVS · ATNM · BCAB · CELU · CPIX · EVAX · PYPD
Explore sector: Healthcare · Biotechnology
More sections of QNTM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks